Toronto Central Regional Cancer Program
The Toronto Central Regional Cancer Program oversees the quality and delivery of cancer services for the residents of Toronto Central.
Service Partners
Odette Cancer Centre
Opened in 1982 on the campus of Sunnybrook Hospital — now known as the Sunnybrook Health Sciences Centre — the Odette Cancer Centre sees 10,000 new patients per year. It boasts expert multidisciplinary health teams as well as state-of-the-art facilities that include 13 radiation treatment machines a new, state-of-the art Gamma Knife Icon, and an MR-Linac that we will installed in 2017.
In addition to providing the full spectrum of patient care, including preventive oncology, surgical oncology, chemotherapy, radiation oncology, medical imaging, psychosocial and palliative care, the Odette Cancer Centre is also intensively engaged in research, education and community outreach. The centre offers specialized clinics, including a clinic for women with locally advanced breast cancer, a program for young women with breast cancer and a clinic for women with gynecological malignancies who have sexual concerns.
Odette Cancer Centre offers specialty residency training and fellowship programs in partnership with the University of Toronto.
Princess Margaret Cancer Centre
Opened in May 1958, the Princess Margaret Cancer Centre is an internationally recognized leader in the fight against cancer. Clinical and research staff include experts in oncology, with specialties that include surgical oncology, bone marrow transplantation, chemotherapy, hematology, radiation treatment, medical imaging and psychosocial oncology.
The hospital underwent a $15-million renovation completed in 1998. This renovation created treatment centres focusing on specific cancers including breast, prostate, brain tumours, and head and neck cancers. The hospital’s 750,000-square foot facility houses 202 patient beds, 350 ambulatory clinics, 397,000-square feet of research space, and 18 radiation treatment machines in special underground concrete bunkers.
The cancer centre, part of the University Health Network, celebrated its 50th anniversary in 2008. During these 5 decades, the hospital treated more than 350,000 cancer patients. In 2014, the Princess Margaret Cancer Centre treated 17,460 new patients and provided diagnosis, treatment and follow-up care at 370,000 clinic visits.
Over the past 20 years, there has been steady growth in the oncology programs at Princess Margaret Cancer Centre.
To continue to meet the demand for services and to improve the patient experience, the cancer centre began a multi-year renovation in mid-2017.
Partner Hospitals
Vice-Presidents
Cancer Care Ontario Regional Vice-Presidents, Toronto Central Regional Cancer Program
Dr. Monika Krzyzanowska
Chief, Odette Cancer Program, Sunnybrook Health Sciences Centre and Regional Vice President, Cancer Services, Toronto Central North, Ontario Health (Cancer Care Ontario)
Dr. Krzyzanowska is a distinguished medical professional with a rich academic background. She graduated from the University of Toronto and completed her residency training in internal medicine and medical oncology at the same institution, followed by a prestigious fellowship at the Dana-Farber Cancer Institute in Boston. She obtained a Master of Public Health from Harvard School of Public Health.
Dr. Krzyzanowska holds certification in Internal Medicine and Medical Oncology from the Royal College of Physicians and Surgeons of Canada. She currently serves as a Professor in the Department of Medicine, Temerty Faculty of Medicine, and the Institute for Health Policy, Management & Evaluation at the University of Toronto, where she contributes to research and education in the field.
In 2004, Dr. Krzyzanowska joined Princess Margaret Cancer Centre (PM) as an attending physician in medical oncology where she practiced caring for patients with gastrointestinal and endocrine malignancies. Since that time, she has held numerous leadership positions at PM focused on advancing the quality of cancer care. Since 2018, she has also been the Department Division Director, Medical Oncology, University of Toronto. Dr. Krzyzanowska has significant experience as a health systems leader through her positions in academic medicine and at Cancer Care Ontario and the American Society of Clinical Oncology. Dr. Krzyzanowska has authored over 200 journal articles in peer-reviewed publications. Her research has been supported by Canadian Institutes of Health Research, Canadian Cancer Society and the Ontario Institute for Cancer Research. She has also received numerous teaching, leadership, and mentorship awards, including the 2023 Mentor of the Year award, Women in Cancer – All in Cancer (WinC-AllinC); 2022 Physician Quality and Safety Award, UHN; 2022 Outstanding Contribution to Cancer Education Team Award, PM; and 2018 Department of Medicine Award in Quality and Innovation, University of Toronto.
Dr. Krzyzanowska began her new role as Chief, Odette Cancer Program, Sunnybrook Health Sciences Centre and Regional Vice President, Cancer Services, Toronto Central North, Ontario Health (Cancer Care Ontario) on June 1, 2024.
Dr. Keith Stewart
Dr. Keith Stewart is the Vice-President, Cancer, and Director of the Princess Margaret Cancer Program, University Health Network, and Regional Vice-President, Toronto Central South Regional Cancer Program, Ontario Health.
Previously, Dr. Stewart was the Carlson and Nelson Endowed Director of the Mayo Clinic Center for Individualized Medicine, and recognized as the Vasek and Anna Maria Polak Professor of Cancer Research.
Dr. Stewart received his medical degree at Aberdeen University Medical School, and trained in internal medicine and hematology in Glasgow, Kingston, Toronto and Boston. He was active staff at the Toronto General and Princess Margaret hospitals from 1992 to 2005, and held the J. Gerald Scott/David G. Whitmore Chair in Hematology and Gene Therapy at the University of Toronto. In 2002, he completed a Master in Business Administration at the Ivey Business School, University of Western Ontario.
Dr. Stewart has served in several leadership roles across both research and clinical practice in Toronto and at the Mayo Clinic, including as director of Research at Toronto General Hospital, and founding director of the McLaughlin Centre for Molecular Medicine at the University of Toronto. At the Mayo Clinic, he was the dean for Research in Arizona, and a member of the Arizona Executive Operations Team and Clinical Practice committee. He has served on multiple boards for both non-profit and commercial organizations. Currently, he is a non-executive board member with Genomics England, a member of the advisory boards of Helix, Veritas Genetics, and Tempus, and a member of the Multiple Myeloma Research Foundation Investment Committee.